Premium aesthetic brand Belluxi successfully debuted at AMWC 2025, the world's largest aesthetic and anti-aging congress, introducing its next-gen aesthetic solution based on Solubilized PCL technology. Belluxi aims to redefine beauty standards with its CPR principle (Clear Pore, Perfect Tone, Restore Line) enhancing skin regrowth and aesthetics. It received nominations in 'Best Injectable' and 'Best Skin Regenerative Aesthetic Solutions' categories, gaining attention from global experts. AMWC, held annually in Monaco, is a symbolic platform in the aesthetic medicine industry. Belluxi, owned by KBH CARE, is set to expand its global partnerships and boost exports through future exhibitions like Dubai Derma. KBH CARE aims for market leadership and brand recognition through continuous participation in major global shows.
